The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy

<i>Background and Objective</i>: This study was conducted to evaluate the diagnostic performance of various biomarkers for steatosis, fibrosis, and inflammation in comparison to a liver biopsy (LB) in patients with nonalcoholic fatty liver disease (NAFLD). <i>Materials and Methods:...

Full description

Bibliographic Details
Main Authors: Ivana Mikolasevic, Viktor Domislovic, Irena Krznaric-Zrnic, Zeljko Krznaric, Lucija Virovic-Jukic, Sanja Stojsavljevic, Ivica Grgurevic, Sandra Milic, Ivan Vukoja, Petra Puz, Merica Aralica, Goran Hauser
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/58/2/252
_version_ 1797478277820973056
author Ivana Mikolasevic
Viktor Domislovic
Irena Krznaric-Zrnic
Zeljko Krznaric
Lucija Virovic-Jukic
Sanja Stojsavljevic
Ivica Grgurevic
Sandra Milic
Ivan Vukoja
Petra Puz
Merica Aralica
Goran Hauser
author_facet Ivana Mikolasevic
Viktor Domislovic
Irena Krznaric-Zrnic
Zeljko Krznaric
Lucija Virovic-Jukic
Sanja Stojsavljevic
Ivica Grgurevic
Sandra Milic
Ivan Vukoja
Petra Puz
Merica Aralica
Goran Hauser
author_sort Ivana Mikolasevic
collection DOAJ
description <i>Background and Objective</i>: This study was conducted to evaluate the diagnostic performance of various biomarkers for steatosis, fibrosis, and inflammation in comparison to a liver biopsy (LB) in patients with nonalcoholic fatty liver disease (NAFLD). <i>Materials and Methods:</i> This was a cross-sectional study that included 135 patients with biopsy-proven NAFLD. Fatty liver index (FLI), hepatic steatosis index (HSI), cell death markers (CK-18 M30 and CK-18 M65), FIB-4 index, NAFLD fibrosis score (NFS), BARD, and AST to platelet ratio index (APRI) were calculated and analysed. <i>Results:</i> FLI, HSI scores, and the cell death biomarkers showed poor diagnostic accuracy for steatosis detection and quantification, with an area under the curve (AUC) of <0.70. The cell death biomarkers likewise did not perform well for the detection of nonalcoholic steatohepatitis (NASH) (AUC < 0.7). As for the fibrosis staging, only APRI and the cell death biomarkers had moderate accuracy (AUC > 0.7) for advanced fibrosis, whereas FIB-4, BARD, and NFS scores demonstrated poor performance (AUC < 0.70). However, a combination of FIB-4 and NFS with the cell death biomarkers had moderate accuracy for advanced (≥F3) fibrosis detection, with an AUC of >0.70. <i>Conclusions:</i> In this first study on Croatian patients with NAFLD, serum biomarkers demonstrated poor diagnostic performance for the noninvasive diagnosis of liver steatosis and NASH. APRI and the cell death biomarkers had only moderate accuracy for diagnosing advanced fibrosis, as did the combination of FIB-4 and NFS with the cell death biomarkers. Further studies regarding serum biomarkers for all NAFLD stages are needed.
first_indexed 2024-03-09T21:29:39Z
format Article
id doaj.art-8d0f214beac849c1af6126ab0b1fd21c
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-09T21:29:39Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-8d0f214beac849c1af6126ab0b1fd21c2023-11-23T21:00:25ZengMDPI AGMedicina1010-660X1648-91442022-02-0158225210.3390/medicina58020252The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver BiopsyIvana Mikolasevic0Viktor Domislovic1Irena Krznaric-Zrnic2Zeljko Krznaric3Lucija Virovic-Jukic4Sanja Stojsavljevic5Ivica Grgurevic6Sandra Milic7Ivan Vukoja8Petra Puz9Merica Aralica10Goran Hauser11Department of Gastroenterology, University Hospital Center Rijeka, 51000 Rijeka, CroatiaDepartment for Gastroenterology and Hepatology, University Hospital Center Zagreb, 10000 Zagreb, CroatiaDepartment of Gastroenterology, University Hospital Center Rijeka, 51000 Rijeka, CroatiaDepartment for Gastroenterology and Hepatology, University Hospital Center Zagreb, 10000 Zagreb, CroatiaFaculty of Medicine, 10000 Zagreb, CroatiaDepartment of Gastroenterology, University Hospital Center “Sestre Milosrdnice”, 10000 Zagreb, CroatiaFaculty of Medicine, 10000 Zagreb, CroatiaDepartment of Gastroenterology, University Hospital Center Rijeka, 51000 Rijeka, CroatiaDepartment of Internal medicine, General Hospital Pozega, 34000 Požega, CroatiaDepartment of Internal medicine, General Hospital Koprivnica, 48000 Koprivnica, CroatiaClinical Institute for Laboratory Diagnostics, Clinical Hospital Centre, 51000 Rijeka, CroatiaDepartment of Gastroenterology, University Hospital Center Rijeka, 51000 Rijeka, Croatia<i>Background and Objective</i>: This study was conducted to evaluate the diagnostic performance of various biomarkers for steatosis, fibrosis, and inflammation in comparison to a liver biopsy (LB) in patients with nonalcoholic fatty liver disease (NAFLD). <i>Materials and Methods:</i> This was a cross-sectional study that included 135 patients with biopsy-proven NAFLD. Fatty liver index (FLI), hepatic steatosis index (HSI), cell death markers (CK-18 M30 and CK-18 M65), FIB-4 index, NAFLD fibrosis score (NFS), BARD, and AST to platelet ratio index (APRI) were calculated and analysed. <i>Results:</i> FLI, HSI scores, and the cell death biomarkers showed poor diagnostic accuracy for steatosis detection and quantification, with an area under the curve (AUC) of <0.70. The cell death biomarkers likewise did not perform well for the detection of nonalcoholic steatohepatitis (NASH) (AUC < 0.7). As for the fibrosis staging, only APRI and the cell death biomarkers had moderate accuracy (AUC > 0.7) for advanced fibrosis, whereas FIB-4, BARD, and NFS scores demonstrated poor performance (AUC < 0.70). However, a combination of FIB-4 and NFS with the cell death biomarkers had moderate accuracy for advanced (≥F3) fibrosis detection, with an AUC of >0.70. <i>Conclusions:</i> In this first study on Croatian patients with NAFLD, serum biomarkers demonstrated poor diagnostic performance for the noninvasive diagnosis of liver steatosis and NASH. APRI and the cell death biomarkers had only moderate accuracy for diagnosing advanced fibrosis, as did the combination of FIB-4 and NFS with the cell death biomarkers. Further studies regarding serum biomarkers for all NAFLD stages are needed.https://www.mdpi.com/1648-9144/58/2/252nonalcoholic fatty liver diseasebiomarkerssteatosisfibrosisinflammation
spellingShingle Ivana Mikolasevic
Viktor Domislovic
Irena Krznaric-Zrnic
Zeljko Krznaric
Lucija Virovic-Jukic
Sanja Stojsavljevic
Ivica Grgurevic
Sandra Milic
Ivan Vukoja
Petra Puz
Merica Aralica
Goran Hauser
The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
Medicina
nonalcoholic fatty liver disease
biomarkers
steatosis
fibrosis
inflammation
title The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
title_full The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
title_fullStr The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
title_full_unstemmed The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
title_short The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
title_sort accuracy of serum biomarkers in the diagnosis of steatosis fibrosis and inflammation in patients with nonalcoholic fatty liver disease in comparison to a liver biopsy
topic nonalcoholic fatty liver disease
biomarkers
steatosis
fibrosis
inflammation
url https://www.mdpi.com/1648-9144/58/2/252
work_keys_str_mv AT ivanamikolasevic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT viktordomislovic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT irenakrznariczrnic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT zeljkokrznaric theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT lucijavirovicjukic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT sanjastojsavljevic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT ivicagrgurevic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT sandramilic theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT ivanvukoja theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT petrapuz theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT mericaaralica theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT goranhauser theaccuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT ivanamikolasevic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT viktordomislovic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT irenakrznariczrnic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT zeljkokrznaric accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT lucijavirovicjukic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT sanjastojsavljevic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT ivicagrgurevic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT sandramilic accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT ivanvukoja accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT petrapuz accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT mericaaralica accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy
AT goranhauser accuracyofserumbiomarkersinthediagnosisofsteatosisfibrosisandinflammationinpatientswithnonalcoholicfattyliverdiseaseincomparisontoaliverbiopsy